Udvalgte virksomhedsoplysninger fra CVR via Datafordeleren, suppleret med tidligere LEI-oplysninger. Personligt ejede virksomheder vises uden gadeadresse og postnummer. Mangelfulde og beskyttede poster kan være udeladt. Udvalget er ikke et historisk totalarkiv over alle danske CVR-numre.

Bekendtgørelse om frivillig forudgående gennemsigtighed · 13. marts 2024

2024-0666349 - Perifusion System

Aarhus Universitet offentliggjorde 13. marts 2024 en bekendtgørelse om frivillig forudgående gennemsigtighed om »2024-0666349 - Perifusion System«. Den samlede kontraktværdi er 511.566 kr.

Type
Bekendtgørelse om frivillig forudgående gennemsigtighed
Ordregiver
Aarhus Universitet
By
Aarhus C
Offentliggjort
13. marts 2024
Kontrakttype
Varer
Procedure
Udbud med forhandling uden forudgående offentliggørelse
Kontraktværdi
511.566 kr.
CPV-koder
38000000, 38432000
Udførelsessted (NUTS)
DK042
TED-nummer
150732-2024

Beskrivelse fra ordregiveren

The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution infusion capacity, real-time monitoring capabilities, customizable experimental setups, and compatibility with various laboratory protocols/assays. These specifications are crucial for our research and experimental endeavors, as they enable us to accurately measure and analyze physiological parameters with utmost precision and efficiency related to our research interests in studying kidney disease.The advanced specifications offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary for our laboratory due to the intricate nature of our research projects and the critical need for reliable precise drug delivery or precise incubation conditions. Without these features, we would face significant limitations in our ability to accurately study and understand complex physiological phenomena, potentially impeding our progress and hindering the advancement of our scientific objectives.To the best of our knowledge, no alternative suppliers have come to our attention, the distinctive combination of features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The conclusion drawn from our analysis is that, given the absence of viable alternatives known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our requirements, providing us with the necessary tools and support to advance our research endeavours successfully.

Andre bekendtgørelser fra Aarhus Universitet

Kilde

Bekendtgørelsen er offentliggjort i TED (nr. 150732-2024). Teksten er ordregiverens egen. Udbudsmaterialet og eventuelle rettelser findes hos ordregiveren eller i TED. Genbrug med kildeangivelse (Kommissionens afgørelse 2011/833/EU).